img

Global Retinal Disorder Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Retinal Disorder Treatment Market Research Report 2024

According to MRAResearch’s new survey, global Retinal Disorder Treatment market is projected to reach US$ 10890 million in 2033, increasing from US$ 7860.7 million in 2022, with the CAGR of 4.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Retinal Disorder Treatment market research.
Key companies engaged in the Retinal Disorder Treatment industry include Santen Pharmaceutical, REGENERON, Graybug Vision, Takeda Pharmaceuticals, Bayer, Roche-Genentech, Acucela and Pfizer, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Retinal Disorder Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Retinal Disorder Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Retinal Disorder Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Santen Pharmaceutical
REGENERON
Graybug Vision
Takeda Pharmaceuticals
Bayer
Roche-Genentech
Acucela
Pfizer
Segment by Type
Gels
Capsules & Tablets
Eye Drops
Ointments

Segment by Application


Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Retinal Disorder Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Disorder Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Gels
1.2.3 Capsules & Tablets
1.2.4 Eye Drops
1.2.5 Ointments
1.3 Market by Application
1.3.1 Global Retinal Disorder Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Retinal Disorder Treatment Market Perspective (2018-2033)
2.2 Retinal Disorder Treatment Growth Trends by Region
2.2.1 Global Retinal Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Retinal Disorder Treatment Historic Market Size by Region (2018-2023)
2.2.3 Retinal Disorder Treatment Forecasted Market Size by Region (2024-2033)
2.3 Retinal Disorder Treatment Market Dynamics
2.3.1 Retinal Disorder Treatment Industry Trends
2.3.2 Retinal Disorder Treatment Market Drivers
2.3.3 Retinal Disorder Treatment Market Challenges
2.3.4 Retinal Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retinal Disorder Treatment Players by Revenue
3.1.1 Global Top Retinal Disorder Treatment Players by Revenue (2018-2023)
3.1.2 Global Retinal Disorder Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Retinal Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Retinal Disorder Treatment Revenue
3.4 Global Retinal Disorder Treatment Market Concentration Ratio
3.4.1 Global Retinal Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Disorder Treatment Revenue in 2022
3.5 Retinal Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Retinal Disorder Treatment Product Solution and Service
3.7 Date of Enter into Retinal Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Disorder Treatment Breakdown Data by Type
4.1 Global Retinal Disorder Treatment Historic Market Size by Type (2018-2023)
4.2 Global Retinal Disorder Treatment Forecasted Market Size by Type (2024-2033)
5 Retinal Disorder Treatment Breakdown Data by Application
5.1 Global Retinal Disorder Treatment Historic Market Size by Application (2018-2023)
5.2 Global Retinal Disorder Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Retinal Disorder Treatment Market Size (2018-2033)
6.2 North America Retinal Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Retinal Disorder Treatment Market Size by Country (2018-2023)
6.4 North America Retinal Disorder Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Retinal Disorder Treatment Market Size (2018-2033)
7.2 Europe Retinal Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Retinal Disorder Treatment Market Size by Country (2018-2023)
7.4 Europe Retinal Disorder Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Retinal Disorder Treatment Market Size (2018-2033)
8.2 Asia-Pacific Retinal Disorder Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Retinal Disorder Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Retinal Disorder Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Retinal Disorder Treatment Market Size (2018-2033)
9.2 Latin America Retinal Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Retinal Disorder Treatment Market Size by Country (2018-2023)
9.4 Latin America Retinal Disorder Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retinal Disorder Treatment Market Size (2018-2033)
10.2 Middle East & Africa Retinal Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Retinal Disorder Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Retinal Disorder Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Santen Pharmaceutical
11.1.1 Santen Pharmaceutical Company Detail
11.1.2 Santen Pharmaceutical Business Overview
11.1.3 Santen Pharmaceutical Retinal Disorder Treatment Introduction
11.1.4 Santen Pharmaceutical Revenue in Retinal Disorder Treatment Business (2018-2023)
11.1.5 Santen Pharmaceutical Recent Development
11.2 REGENERON
11.2.1 REGENERON Company Detail
11.2.2 REGENERON Business Overview
11.2.3 REGENERON Retinal Disorder Treatment Introduction
11.2.4 REGENERON Revenue in Retinal Disorder Treatment Business (2018-2023)
11.2.5 REGENERON Recent Development
11.3 Graybug Vision
11.3.1 Graybug Vision Company Detail
11.3.2 Graybug Vision Business Overview
11.3.3 Graybug Vision Retinal Disorder Treatment Introduction
11.3.4 Graybug Vision Revenue in Retinal Disorder Treatment Business (2018-2023)
11.3.5 Graybug Vision Recent Development
11.4 Takeda Pharmaceuticals
11.4.1 Takeda Pharmaceuticals Company Detail
11.4.2 Takeda Pharmaceuticals Business Overview
11.4.3 Takeda Pharmaceuticals Retinal Disorder Treatment Introduction
11.4.4 Takeda Pharmaceuticals Revenue in Retinal Disorder Treatment Business (2018-2023)
11.4.5 Takeda Pharmaceuticals Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Retinal Disorder Treatment Introduction
11.5.4 Bayer Revenue in Retinal Disorder Treatment Business (2018-2023)
11.5.5 Bayer Recent Development
11.6 Roche-Genentech
11.6.1 Roche-Genentech Company Detail
11.6.2 Roche-Genentech Business Overview
11.6.3 Roche-Genentech Retinal Disorder Treatment Introduction
11.6.4 Roche-Genentech Revenue in Retinal Disorder Treatment Business (2018-2023)
11.6.5 Roche-Genentech Recent Development
11.7 Acucela
11.7.1 Acucela Company Detail
11.7.2 Acucela Business Overview
11.7.3 Acucela Retinal Disorder Treatment Introduction
11.7.4 Acucela Revenue in Retinal Disorder Treatment Business (2018-2023)
11.7.5 Acucela Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Retinal Disorder Treatment Introduction
11.8.4 Pfizer Revenue in Retinal Disorder Treatment Business (2018-2023)
11.8.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Retinal Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Gels
Table 3. Key Players of Capsules & Tablets
Table 4. Key Players of Eye Drops
Table 5. Key Players of Ointments
Table 6. Global Retinal Disorder Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Retinal Disorder Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Retinal Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Retinal Disorder Treatment Market Share by Region (2018-2023)
Table 10. Global Retinal Disorder Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Retinal Disorder Treatment Market Share by Region (2024-2033)
Table 12. Retinal Disorder Treatment Market Trends
Table 13. Retinal Disorder Treatment Market Drivers
Table 14. Retinal Disorder Treatment Market Challenges
Table 15. Retinal Disorder Treatment Market Restraints
Table 16. Global Retinal Disorder Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Retinal Disorder Treatment Market Share by Players (2018-2023)
Table 18. Global Top Retinal Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorder Treatment as of 2022)
Table 19. Ranking of Global Top Retinal Disorder Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Retinal Disorder Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Retinal Disorder Treatment Product Solution and Service
Table 23. Date of Enter into Retinal Disorder Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Retinal Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Retinal Disorder Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Retinal Disorder Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Retinal Disorder Treatment Revenue Market Share by Type (2024-2033)
Table 29. Global Retinal Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Retinal Disorder Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Retinal Disorder Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Retinal Disorder Treatment Revenue Market Share by Application (2024-2033)
Table 33. North America Retinal Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Retinal Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Retinal Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Retinal Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Retinal Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Retinal Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Retinal Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Retinal Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Retinal Disorder Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Retinal Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Retinal Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Retinal Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Retinal Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Retinal Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Retinal Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. Santen Pharmaceutical Company Detail
Table 49. Santen Pharmaceutical Business Overview
Table 50. Santen Pharmaceutical Retinal Disorder Treatment Product
Table 51. Santen Pharmaceutical Revenue in Retinal Disorder Treatment Business (2018-2023) & (US$ Million)
Table 52. Santen Pharmaceutical Recent Development
Table 53. REGENERON Company Detail
Table 54. REGENERON Business Overview
Table 55. REGENERON Retinal Disorder Treatment Product
Table 56. REGENERON Revenue in Retinal Disorder Treatment Business (2018-2023) & (US$ Million)
Table 57. REGENERON Recent Development
Table 58. Graybug Vision Company Detail
Table 59. Graybug Vision Business Overview
Table 60. Graybug Vision Retinal Disorder Treatment Product
Table 61. Graybug Vision Revenue in Retinal Disorder Treatment Business (2018-2023) & (US$ Million)
Table 62. Graybug Vision Recent Development
Table 63. Takeda Pharmaceuticals Company Detail
Table 64. Takeda Pharmaceuticals Business Overview
Table 65. Takeda Pharmaceuticals Retinal Disorder Treatment Product
Table 66. Takeda Pharmaceuticals Revenue in Retinal Disorder Treatment Business (2018-2023) & (US$ Million)
Table 67. Takeda Pharmaceuticals Recent Development
Table 68. Bayer Company Detail
Table 69. Bayer Business Overview
Table 70. Bayer Retinal Disorder Treatment Product
Table 71. Bayer Revenue in Retinal Disorder Treatment Business (2018-2023) & (US$ Million)
Table 72. Bayer Recent Development
Table 73. Roche-Genentech Company Detail
Table 74. Roche-Genentech Business Overview
Table 75. Roche-Genentech Retinal Disorder Treatment Product
Table 76. Roche-Genentech Revenue in Retinal Disorder Treatment Business (2018-2023) & (US$ Million)
Table 77. Roche-Genentech Recent Development
Table 78. Acucela Company Detail
Table 79. Acucela Business Overview
Table 80. Acucela Retinal Disorder Treatment Product
Table 81. Acucela Revenue in Retinal Disorder Treatment Business (2018-2023) & (US$ Million)
Table 82. Acucela Recent Development
Table 83. Pfizer Company Detail
Table 84. Pfizer Business Overview
Table 85. Pfizer Retinal Disorder Treatment Product
Table 86. Pfizer Revenue in Retinal Disorder Treatment Business (2018-2023) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Disorder Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Retinal Disorder Treatment Market Share by Type: 2022 VS 2033
Figure 3. Gels Features
Figure 4. Capsules & Tablets Features
Figure 5. Eye Drops Features
Figure 6. Ointments Features
Figure 7. Global Retinal Disorder Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Retinal Disorder Treatment Market Share by Application: 2022 VS 2033
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Retinal Disorder Treatment Report Years Considered
Figure 13. Global Retinal Disorder Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Retinal Disorder Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Retinal Disorder Treatment Market Share by Region: 2022 VS 2033
Figure 16. Global Retinal Disorder Treatment Market Share by Players in 2022
Figure 17. Global Top Retinal Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorder Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Retinal Disorder Treatment Revenue in 2022
Figure 19. North America Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Retinal Disorder Treatment Market Share by Country (2018-2033)
Figure 21. United States Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Retinal Disorder Treatment Market Share by Country (2018-2033)
Figure 25. Germany Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Retinal Disorder Treatment Market Share by Region (2018-2033)
Figure 33. China Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Retinal Disorder Treatment Market Share by Country (2018-2033)
Figure 41. Mexico Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Retinal Disorder Treatment Market Share by Country (2018-2033)
Figure 45. Turkey Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Retinal Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Santen Pharmaceutical Revenue Growth Rate in Retinal Disorder Treatment Business (2018-2023)
Figure 48. REGENERON Revenue Growth Rate in Retinal Disorder Treatment Business (2018-2023)
Figure 49. Graybug Vision Revenue Growth Rate in Retinal Disorder Treatment Business (2018-2023)
Figure 50. Takeda Pharmaceuticals Revenue Growth Rate in Retinal Disorder Treatment Business (2018-2023)
Figure 51. Bayer Revenue Growth Rate in Retinal Disorder Treatment Business (2018-2023)
Figure 52. Roche-Genentech Revenue Growth Rate in Retinal Disorder Treatment Business (2018-2023)
Figure 53. Acucela Revenue Growth Rate in Retinal Disorder Treatment Business (2018-2023)
Figure 54. Pfizer Revenue Growth Rate in Retinal Disorder Treatment Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed